CNTF and amyotrophic lateral sclerosis: These observations led human recombinant CNTF to be tested in amyotrophic lateral sclerosis patients where, although it failed to slow disease progression, it unexpectedly induced anorexia and weight loss (ACTS, 1996; Miller et al., 1996).